UPC Analytics
DEEN
Übersicht · Eingereicht: 4. Juli 2025

UPC_CFI_624/2025

ANALYTE SENSOR METHODS

Einstweilige MaßnahmenEinstweilige MaßnahmenThe Hague LDProvisional measuresCase Closed
Abdeckung: Teilweise.Begründung teilweise extrahiert — einige Abschnitte können unvollständig sein.
Zusammenfassung in einfacher Sprache

Abbott Diabetes Care obtained a preliminary injunction from The Hague Local Division against Sinocare and A. Menarini Diagnostics prohibiting the GlucoMen iCan CGM system across all UPC territories for infringement of EP 4 344 633 (FreeStyle Libre analyte sensor technology). The court also ordered delivery-up of infringing products and disclosure of distribution channels, but rejected Abbott's request for a customs-goods declaration under EU Regulation 608/2013 as unavailable in PI proceedings, and limited the information order to distribution data rather than financial figures.

Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • GlucoMen iCan infringes EP 4 344 633 covering continuous glucose monitoring sensor technology

    KlägerRechtsgrundlage: Art. 62 UPCA; R. 211 RoP

    Hinweis: The Hague Local Division found infringement sufficiently demonstrated for PI purposes and granted the injunction across all UPC member states.

  • Defendants should not be ordered to comply jointly and severally as independent companies

    Beklagter

    Hinweis: Court agreed that Sinocare and Menarini are independent companies and did not impose joint and several liability for the substantive injunction obligations.

Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • Declaration that GlucoMen iCan is 'goods suspected of infringing an IP right' under EU Regulation 608/2013 should be granted as a provisional measure

    KlägerRechtsgrundlage: Art. 2(7)(a) of Regulation (EU) No 608/2013

    Begründung: Court held that such a declaration is not available as a provisional measure regardless of the merits.

  • Information order should include price, sales numbers, and cost data

    KlägerRechtsgrundlage: R. 211 RoP

    Begründung: Court found that financial data is only relevant for damages calculation which is premature at the PI stage; the information order was limited to distribution channels and product origins.

  • Information disclosure should be subject to confidentiality

    Beklagter

    Begründung: Court rejected confidentiality request given the limited scope of the ordered information disclosure.